Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millan

Showing results (181-190 of 224) with videos related to

Pageof 23
Sort By:
Molecular Psychiatry|November 22, 2017
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signalingL Cavalleri, E Merlo Pich, M J Millan, et al.
Experimental Neurology|June 12, 2004
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primateM A Silverdale, S L Nicholson, P Ravenscroft, et al.
Pain|December 1, 1988
Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the ratM J Millan, A Członkowski, B Morris, et al.
European Journal of Pharmacology|October 6, 1998
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding studyA Newman-Tancredi, S Gavaudan, C Conte, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Dekeyne, M Papp, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 1986
A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritisM J Millan, M H Millan, A Członkowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Gobert, F Lejeune, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
Journal of Medicinal Chemistry|March 23, 2001
Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor propertiesA A Cordi, I Berque-Bestel, T Persigand, et al.
Brain Research|November 22, 2001
Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigraA Newman-Tancredi, D Cussac, M Brocco, et al.
Pageof 23

Showing results (181-190 of 224) with videos related to

Sort By:
Pageof 23
Molecular Psychiatry|November 22, 2017
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signalingL Cavalleri, E Merlo Pich, M J Millan, et al.
Experimental Neurology|June 12, 2004
Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primateM A Silverdale, S L Nicholson, P Ravenscroft, et al.
Pain|December 1, 1988
Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the ratM J Millan, A Członkowski, B Morris, et al.
European Journal of Pharmacology|October 6, 1998
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding studyA Newman-Tancredi, S Gavaudan, C Conte, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Dekeyne, M Papp, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 1, 1986
A model of chronic pain in the rat: response of multiple opioid systems to adjuvant-induced arthritisM J Millan, M H Millan, A Członkowski, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Gobert, F Lejeune, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
Journal of Medicinal Chemistry|March 23, 2001
Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor propertiesA A Cordi, I Berque-Bestel, T Persigand, et al.
Brain Research|November 22, 2001
Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigraA Newman-Tancredi, D Cussac, M Brocco, et al.
Pageof 23